Release Date: 10/05/19 19:13 Summary: SGX-ST Quarterly Financial Statements - Q3FY2019 Price Sensitive: No Download Document 487.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago